KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Resmed (RMD) Interest & Investment Income (2016 - 2025)

Resmed's Interest & Investment Income history spans 16 years, with the latest figure at $7.9 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 1125.68% year-over-year to $7.9 million; the TTM value through Dec 2025 reached $23.3 million, up 220.17%, while the annual FY2025 figure was $4.1 million, 109.0% up from the prior year.
  • Interest & Investment Income reached $7.9 million in Q4 2025 per RMD's latest filing, down from $8.8 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $8.8 million in Q3 2025 to a low of -$15.0 million in Q3 2023.
  • Average Interest & Investment Income over 4 years is -$2.1 million, with a median of -$360000.0 recorded in 2021.
  • Peak YoY movement for Interest & Investment Income: plummeted 76.86% in 2021, then surged 1125.68% in 2025.
  • A 4-year view of Interest & Investment Income shows it stood at $59000.0 in 2021, then crashed by 23498.31% to -$13.8 million in 2023, then soared by 94.39% to -$775000.0 in 2024, then soared by 1125.68% to $7.9 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Interest & Investment Income are $7.9 million (Q4 2025), $8.8 million (Q3 2025), and $5.8 million (Q2 2025).